AP-1-independent sensitization to oxidative stress-induced apoptosis by proteasome inhibitors

被引:9
作者
Hiramatsu, N
Kasai, A
Yao, J
Meng, YM
Takeda, M
Maeda, S
Kitamura, M [1 ]
机构
[1] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Tamaho, Yamanashi 4093898, Japan
[2] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Tamaho, Yamanashi 4093898, Japan
[3] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Tamaho, Yamanashi 4093898, Japan
[4] Yamanashi Univ, Interdisciplinary Grad Sch Med & Engn, Dept Biotechnol, Kofu, Yamanashi 4008511, Japan
关键词
proteasome inhibitor; apoptosis; oxidative stress; hydrogen peroxide; activator protein-1; c-Jun N-terminal kinase; extracellular signal-regulated kinase;
D O I
10.1016/j.bbrc.2004.02.081
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrogen peroxide (H2O2) induces apoptosis of mesangial cells via c-Jun N-terminal kinase (JNK)-activator protein-1 (AP-1) and extracellular signal-regulated kinase (ERK)-AP-1 pathways. We recently found that subtoxic doses of proteasome inhibitors, MG132 and lactacystin, dramatically enhanced H2O2-induced apoptosis in mesangial cells. In this report, we examined molecular mechanisms involved in this phenomenon, especially focusing on AP-1 pathways. Reporter assays showed that MG132 induced activation of AP-1. However, pharmacological inhibitors of AP-1, retinoic acid, and curcumin, did not suppress the proapoptotic effect of MG132. Suppression of JNK-AP-1 by transfection with either a dominant-negative mutant of JNK or a dominant-negative mutant of c-Jun did not attenuate the apoptosis enhancement by MG132. Similarly, suppression of ERK-AP-1 by PD98059 or dominant-negative mutants of ERK did not affect the apoptosis-promoting effect of MG132. Interestingly, pretreatment with MG132 did not enhance activation of AP-1 by H2O2. These data suggested a novel, AP-1-independent promotion of apoptosis by proteasome inhibitors. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 32 条
[1]   ACTIVATION OF CAMP AND MITOGEN RESPONSIVE GENES RELIES ON A COMMON NUCLEAR FACTOR [J].
ARIAS, J ;
ALBERTS, AS ;
BRINDLE, P ;
CLARET, FX ;
SMEAL, T ;
KARIN, M ;
FERAMISCO, J ;
MONTMINY, M .
NATURE, 1994, 370 (6486) :226-229
[2]   MESANGIAL CELL APOPTOSIS - THE MAJOR MECHANISM FOR RESOLUTION OF GLOMERULAR HYPERCELLULARITY IN EXPERIMENTAL MESANGIAL PROLIFERATIVE NEPHRITIS [J].
BAKER, AJ ;
MOONEY, A ;
HUGHES, J ;
LOMBARDI, D ;
JOHNSON, RJ ;
SAVILL, J .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :2105-2116
[3]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[4]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[5]   Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells [J].
GonzalezCuadrado, S ;
LopezArmada, MJ ;
GomezGuerrero, C ;
Subira, D ;
GarciaSahuquillo, A ;
OrtizGonzalez, A ;
Neilson, EG ;
Egido, J ;
Ortiz, A .
KIDNEY INTERNATIONAL, 1996, 49 (04) :1064-1070
[6]  
Hashimoto M, 2000, FEW BODY SY, V12, P92
[7]   Anti-apoptotic effect of quercetin: Intervention in the JNK- and ERK-mediated apoptotic pathways [J].
Ishikawa, Y ;
Kitamura, M .
KIDNEY INTERNATIONAL, 2000, 58 (03) :1078-1087
[8]   C-Jun/AP-1, but not NF-kappa B, is a mediator for oxidant-initiated apoptosis in glomerular mesangial cells [J].
Ishikawa, Y ;
Yokoo, T ;
Kitamura, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (02) :496-501
[9]   Deadly encounter: Ubiquitin meets apoptosis [J].
Jesenberger, V ;
Jentsch, S .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (02) :112-121
[10]   The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells [J].
Johnson, TR ;
Stone, K ;
Nikrad, M ;
Yeh, T ;
Zong, WX ;
Thompson, CB ;
Nesterov, A ;
Kraft, AS .
ONCOGENE, 2003, 22 (32) :4953-4963